VALUE OF POLYMORPHISMS rs759853 and rs9640883 AKR1B1 GENE AT THE DIABETIC RETINOPATHY
Keywords:diabetes mellitus 2 types, diabetic retinopathy, gene AKR1B1 polymorphism, rs759853, rs9640883
AbstractDetermination of the importance of AKR1B1 gene polymorphisms rs759853 and rs9640883 at the diabetic retinopathy became an object of this research. In 39 patients with diabetes mellitus 2 types and diabetic retinopathy it was determined gene polymorphisms by method of polymerase chain reaction in real time. It was shown that both polymorphisms were connected with compensation status of diabetes. Existence of the minor genotype AA of rs759853 promoted the bigger retina central thickness that could point to strengthening of macular edema owing to bigger intracellular sorbitol accumulation. Carriers of the minor allele A rs9640883 (genotypes GA and AA) were operated earlier on the average of six years. This points to bigger progressing of retina pathological process in cases with allele A presence.
Щулькин А.В. Генетические маркеры развития диабетической ретинопатии / А.В. Щулькин, А.В. Колесников, О.И. Баренина, А.А. Никифоров // Фундаментальные исследования. – 2014. – № 4–2. – С. 411–414.
Abhary S. A systematic meta-analysis of genetic association studies for diabetic retinopathy //S. Abhary, A.W. Hewitt, K.P. Burdon, J.E. Craig // Diabetes. – 2009. – Vol. 58. – P. 2137–2147.
Abhary S. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility /S. Abhary, K.P. Burdon, K.J. Laurie et al. // Diabetes Care. – 2010. – Vol. 33(8). – P. 834–836.
Asnaghi V. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat / V. Asnaghi, C. Gerhardinger, T. Hoehn et al. // Diabetes. – 2003. – Vol. 52(2). P. 506–511.
Chung S.S. Aldose reductase in diabetic microvascular complications / S.S. Chung, S.K. Chung // Curr Drug Targets. 2005 Jun;6(4):475–86.
Dagher Z. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy / Z. Dagher, Y.S. Park, V. Asnaghi et al. // Diabetes. – 2004. – Vol. 53(9). – P. 2404–2411.
Jane Z. Kuo. Challenges in elucidating the genetics of diabetic retinopathy / Jane Z. Kuo, Tien Y. Wong, Jerome I. Rotter // JAMA. Ophthalmol. – 2014. – Vol. 132(1). – P. 96–107.
Joanna M. Tarr. Pathophysiology of diabetic retinopathy / Joanna M. Tarr, Kirti Kaul, Mohit Chopra et al. // ISRN Ophthalmol. – 2013. – 2013. – P. 343–560.
Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive and resilient / M. Lorenzi // Exp Diabetes Res. 2007;2007:61038. doi: 10.1155/2007/61038.
Obrosova I.G. Aldose reductase polyol inhibitors for diabetic retinopathy / I.G. Obrosova, P.F. Kador // Curr Pharm Biotechnol. – 2011. – Vol. 12(3). – P. 373–385.
Copyright (c) 2019 Archive of Ukrainian Ophthalmology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.